Publications

5674 Results

Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501

Authors
WS Velasquez;D Lew;TM Grogan;CH Spiridonidis;SP Balcerzak;SR Dakhil;TP Miller;K Lanier;RA Chapman;RI Fisher
Journal / Conference
Journal of Clinical Oncology 21(10):1996-2003
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9501

The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial

Authors
PJ Stiff;JM Unger;SJ Forman;AR McCall;M LeBlanc;AP Nademanee;BJ Bolwell;RI Fisher
Journal / Conference
Biology of Blood and Marrow Transplantation 9:529-539
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9011

Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV

Authors
S deVos;U Krug;WK Hofmann;GS Pinkus;SH Swerdlow;W Wachsman;TM Grogan;JW Said;HP Koeffler
Journal / Conference
Diagnostic Molecular Pathology 12(1):35-43
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Directed indices for exploring gene expression data

Authors
M LeBlanc;C Kooperberg;TM Grogan;TP Miller
Journal / Conference
Bioinformatics 19(6):686-693
Year
2003
Research Committee(s)
Lymphoma

Tumor Origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy

Authors
ML Gulley;LJ Swinnen;KT Plaisance Jr;C Schnell;TM Grogan;BG Schneider
Journal / Conference
Transplantation 76(6):959-964
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9239

Determinants of prostate specific antigen (PSA) normalization in prostate cancer (PCa) patients (pts) treated with androgen deprivation (AD) on Southwest Oncology Group (SWOG) study 9346 (INT-0162).

Authors
CM Tangen;M Hussain;G Wilding;EJ Small;L Goldenberg;A Akdas;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 22:396(#1591)
Year
2003
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

African Americans have worse survival in hormone-related cancers. a Southwest Oncology Group (SWOG) study.

Authors
JM Unger;CA Coltman, Jr;FR Appelbaum;B Barlogie;ED Crawford;RI Fisher;DR Gandara;RB Livingston;M Markman;KS Albain
Journal / Conference
Proc of the American Society of Clinical Oncology 22:529(#2127)
Year
2003

Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): initial results from intergroup trial 0139 (RTOG 93-09).

Authors
KS Albain;CB Scott;VR Rusch;AT Turrisi;FA Shepherd;C Smith;DR Gandara;DH Johnson;MR Green;RC Miller
Journal / Conference
Proc of the American Society of Clinical Oncology 22:621(#2497)
Year
2003
Research Committee(s)
Lung
Study Number(s)
SWOG-9336

A phase II study of flavopiridol (Flavo) in patients (pts) with advanced renal cell cancer: results of Southwest Oncology Group trial S0109.

Authors
PJ Van Veldhuizen;JR Faulkner;PN Lara;RC Flanigan;PH Gumerlock;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 22:387(#1553)
Year
2003
Research Committee(s)
Genitourinary
Study Number(s)
S0109

S0003: Paclitaxel/carboplatin (PC) v PC + tirapazamine (PCT) in advanced non-small cell lung cancer (NSCLC). A phase III Southwest Oncology Group (SWOG) trial.

Authors
SK Williamson;JJ Crowley;PN Lara;RW Tucker;J McCoy;DHM Lau;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 22:622(#2502)
Year
2003
Research Committee(s)
Lung
Study Number(s)
S0003